Biological and Medicinal Chemistry

Probing Cellular Outcomes Using Heterobivalent Constructs



Conjugation techniques are central to improving intracellular delivery of bioactive small molecules. However, tracking and assessing the overall biological outcome of these constructs remains poorly understood. We addressed this issue by having developed a focused library of heterobivalent constructs based on Rho kinase inhibitors to probe various scenarios. By comparing induction of a phenotype of interest vs. cell viability vs. cellular uptake, we demonstrate that such conjugates indeed lead to divergent cellular outcomes.

Version notes

version 1.0


Thumbnail image of Bhadoria et al_Manuscript.pdf

Supplementary material

Thumbnail image of Bhadoria et al_SI.pdf
Bhadoria et al SI